32-240 Cells Microbiology Automatic Blood Culture System for Sepsis

Name: 32-240 Cells Microbiology Automatic Blood Culture System for Sepsis
Brand: GUANGZHOU ICLEAR HEALTHCARE LIMITED
SKU: 1903327695

Guangdong, ChinaGUANGZHOU ICLEAR HEALTHCARE LIMITED

US$3,000.00-8,000.00

1 Piece

Product profile

Customization

Available

Classification

Biological Diagnostics

Type

Automatic Blood Culture Detection System

Model NO.

CHL-Dt32/64/112/240

Certification

CE, FDA, ISO13485

Group

Any Range

Positions

32-240 Cells

Transport Package

Carton Package

Specification

135mm x 65mm x 34.5mm 145 grams

Trademark

ICLEAR

Origin

China

HS Code

9027500000

Production Capacity

10000pieces/Year

Company profile

Importers and ExportersHigh Repeat Buyers ChoicePatents Awarded

GUANGZHOU ICLEAR HEALTHCARE LIMITED

Guangdong, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2014-05-01Nearest Port: GUANGZHOU, SHENZHEN, HONGKONGAverage Response Time: ≤9.81hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DAT, DDP, DAP, CIP, CPT, FCA

AI-Powered supplier vetting

SummaryGUANGZHOU ICLEAR HEALTHCARE LIMITED is a China-based limited company identified as both a trading company and manufacturer/factory, offering medical, laboratory, surgical, veterinary, endoscopy, IVD, and audiometry/ENT products. It reports inventory capability, OEM and ODM services, multiple customization options, new products within the past year, and service procedures for corrective actions and customer complaints. However, the available information does not confirm certifications, quality assurance status, outsourcing controls, raw-material traceability, or financial performance. Its international service infrastructure appears limited: it reports no overseas warehouse, showroom, agents, branches, or offline trade-show participation, and lists zero countries with overseas services. It states that it has supplied equipment to more than 80 hospitals and clinics worldwide, but no named customer cases are provided.

Supplier typeThe supplier is identified as both a trading company and manufacturer/factory, organized as a limited company in China. Its stated product scope covers multiple medical and laboratory categories, indicating a broad supplier profile rather than a narrowly specialized business.

After-Sales capabilityThe company description claims professional after-sales service, and the supplier reports clear procedures and followed records for handling customer complaints and corrective/preventive actions. However, no specific response times, service coverage, repair resources, or overseas support structure are provided.

R&D capabilityThe supplier reports new products within the past year, one R&D engineer, and ODM services, and states that it provides OEM services for popular brands. It does not provide 3D software design services and has no available SDK, so the evidence supports product-development activity but not comprehensive technical innovation capability.

Production capacityThe supplier is classified as both a trading company and manufacturer/factory and reports inventory capability. However, its outsourcing manufacturing procedure and manufacturing-capacity contract status are unknown, so production scale, process control, and manufacturing governance are not fully verified.

Customization capabilityThe supplier explicitly lists customization from samples, customization from designs, full customization, minor customization, and flexible customization, and also reports ODM availability. These statements provide direct evidence of broad customization support.

Client casesThe company states that it has supplied medical equipment to more than 80 hospitals and clinics worldwide. This is evidence of claimed customer experience, but no customer names, project details, locations, or independently verifiable case information are provided.